lunes, 11 de noviembre de 2024

FDA approves obecabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-obecabtagene-autoleucel-adults-relapsed-or-refractory-b-cell-precursor-acute?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario